The present invention relates to 1,4-dihydro-4-oxo-1,8-napthpyridine analogs of the formula ##STR00001## and pharmaceutically acceptable salts, esters, and prodrugs thereof, wherein A, X, W and Y are substituents. The present invention relates to methods for using such compounds.